A carregar...

The economics of treating chronic hepatitis B in Asia

Chronic hepatitis B constitutes a significant health and economic burden to Asian countries. Six medications are now approved for the treatment of chronic hepatitis B, but there is still significant uncertainty with regards to treatment outcomes, cost impact, and benefits in view of the absence of l...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Dan, Yock Young, Aung, Myat Oo, Lim, Seng Gee
Formato: Artigo
Idioma:Inglês
Publicado em: Springer-Verlag 2008
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2716880/
https://ncbi.nlm.nih.gov/pubmed/19669256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12072-008-9049-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!